Please select the option that best describes you:
How you treat large B-cell lymphoma with IRF4 rearrangement?
Does your approach differ from de novo LBCL, and do you consider shortened therapy courses for limited stage disease?
Does your approach differ from de novo LBCL, and do you consider shortened therapy courses for limited stage disease?